Synthesis and growth inhibition activity of fluorinated derivatives of tamoxifen

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Cancer Biology

Background:

• Tamoxifen is a widely used selective estrogen receptor modulator (SERM) for breast cancer treatment.
• Fluorinated analogs of drugs are often explored to improve pharmacokinetic properties and efficacy.
• Understanding structure-activity relationships is crucial for developing novel anticancer agents.

Purpose of the Study:

• To design and synthesize novel fluorinated derivatives of tamoxifen.
• To evaluate the in vitro anticancer activity of these derivatives against a panel of human tumor cell lines.
• To compare the efficacy of the new compounds with tamoxifen and investigate the behavior of geometrical isomers.

Main Methods:

• Synthesis of 11 novel fluorinated tamoxifen derivatives using established organic chemistry techniques.
• In vitro cell growth inhibition assays using human tumor cell lines: HT-29, M21, MCF7, and MDA-MB-231.
• Determination of half-maximal inhibitory concentration (GI50) values for all synthesized compounds and tamoxifen.

Main Results:

• The synthesized fluorinated tamoxifen derivatives exhibited varying degrees of growth inhibition against the tested cancer cell lines.
• Generally, the GI50 values were comparable or slightly higher than those of tamoxifen.
• One derivative demonstrated significant activity against the MCF7 cell line with a GI50 of 3.6 μM.
• Unlike tamoxifen, both geometrical isomers of the fluorinated derivatives displayed similar activity profiles, suggesting potential in vitro isomerization.

Conclusions:

• The synthesized fluorinated tamoxifen derivatives represent potential anticancer agents with comparable or improved activity over tamoxifen.
• The similar behavior of geometrical isomers warrants further investigation, potentially indicating in vitro isomerization as a key factor.
• These findings contribute to the development of novel tamoxifen analogs for cancer therapy.